| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/10/2006 | US20060177893 Method for producing dipeptides |
| 08/10/2006 | US20060177892 Intracellular formation of peptide conjugates |
| 08/10/2006 | US20060177885 Delta 4,5 glycuronidase and methods of analyzing therewith |
| 08/10/2006 | US20060177881 Antibodies against type A botulinum neurotoxin |
| 08/10/2006 | US20060177875 Tryptase polypeptide and uses thereof |
| 08/10/2006 | US20060177872 Using paramagnetic microparticles coated with a purified recombinant porcine intrinsic factor and chemiluminescence as capture and visualization tools in detection and quantification of vitamin B12 in sample |
| 08/10/2006 | US20060177865 Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| 08/10/2006 | US20060177854 Hereditary hemochromatosis gene |
| 08/10/2006 | US20060177845 UBP1 protease mutant, and its coding sequence, their application and methods of production |
| 08/10/2006 | US20060177831 c-MET kinase binding proteins |
| 08/10/2006 | US20060177828 Alternatively spliced isoform of mitotic centromere-associated kinesin (MCAK) |
| 08/10/2006 | US20060177826 Method of producing recombinant dna molecules |
| 08/10/2006 | US20060177823 Molecules |
| 08/10/2006 | US20060177822 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 08/10/2006 | US20060177817 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 08/10/2006 | US20060177813 Novel high-throughput screening method of drug for bioactive protein |
| 08/10/2006 | US20060177470 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 08/10/2006 | US20060177466 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/10/2006 | US20060177464 Methods and compositions involving LcrV proteins |
| 08/10/2006 | US20060177463 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide |
| 08/10/2006 | US20060177461 Stress proteins and uses therefor |
| 08/10/2006 | US20060177460 Administering to a patient a stress protein joined via a peptide bond to a melanoma antigen to induce or enhanc an immune response against the melanoma antigen |
| 08/10/2006 | US20060177456 Apo-2 receptor antibodies |
| 08/10/2006 | US20060177455 Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 08/10/2006 | US20060177453 Effective in inhibiting tumor cell growth; immunotherapy; purified immunoglobulin; preventing or delaying development of metastasis, treating metastatic cancer, or inhibiting proliferation of metastatic cancer cells |
| 08/10/2006 | US20060177451 Binding molecules for the treatment of myeloid cell malignancies |
| 08/10/2006 | US20060177450 isolated mammalian nucleic acid molecule; antibody; suppressing or modulating metastatic ability of prostate tumor cells, prostate tumor growth or elimination of prostate tumor cells; antitumor agents; gene expression inhbition |
| 08/10/2006 | US20060177449 Antibody and use thereof |
| 08/10/2006 | US20060177447 Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177440 Compositions and methods for detection of antibody binding to cells |
| 08/10/2006 | US20060177428 Expression vector comprising nucleotide sequences coding endothelial growth factor for use in diagnosis, prevention and treatment of tumor disorders |
| 08/10/2006 | US20060177427 DNA coding for endo-beta-galactosidase |
| 08/10/2006 | US20060177422 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide |
| 08/10/2006 | CA2597198A1 Antibodies that bind to epha2 and methods of use thereof |
| 08/10/2006 | CA2597171A1 Antibodies to oncostatin m receptor |
| 08/10/2006 | CA2596514A1 Riproximin , a novel type ii ribosome-inactivating protein and uses thereof |
| 08/10/2006 | CA2595901A1 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 08/10/2006 | CA2595792A1 Cd20 antibody variants and uses thereof |
| 08/10/2006 | CA2594636A1 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | CA2583306A1 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
| 08/09/2006 | EP1688495A1 MU-1 member of the cytokine receptor family |
| 08/09/2006 | EP1688490A1 Dose-dependent promoter originating in humans |
| 08/09/2006 | EP1688439A1 Fused protein composition |
| 08/09/2006 | EP1688437A1 Antibody composition specifically binding to il-5 receptor |
| 08/09/2006 | EP1688436A1 Composition of antibody capable of specifically binding ccr4 |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688433A1 Antibody composition specifically binding to ganglioside gm2 |
| 08/09/2006 | EP1688431A2 Analogs of thymosin alpha 1 |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688037A2 Hepatoblasts and method of isolating same |
| 08/09/2006 | EP1687441A1 Means and methods for the determination of camp in vitro and in vivo |
| 08/09/2006 | EP1687430A1 Immunization against chlamydia infection |
| 08/09/2006 | EP1687428A1 Processes for making acylated insulin |
| 08/09/2006 | EP1687421A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 08/09/2006 | EP1687401A2 Site-specific incorporation of redox active amino acids into proteins |
| 08/09/2006 | EP1687328A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction |
| 08/09/2006 | EP1687029A1 Neutralizing human antibodies to anthrax toxin generated by recall technology |
| 08/09/2006 | EP1687017A2 Methods and compositions for delivering polynucleotides |
| 08/09/2006 | EP1686947A2 Method for the production of bioactive substances from the novel actinomycete taxon mar2 (marinophilus) |
| 08/09/2006 | EP1658366A4 Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof |
| 08/09/2006 | EP1527190A4 Hip1 cancer markers |
| 08/09/2006 | EP1423429B1 Antibodies against caspase-8, their preparation and use |
| 08/09/2006 | EP1423400B1 Evolving new molecular function |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1307481B1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 08/09/2006 | EP1290032B1 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 08/09/2006 | EP1200604B1 Production of proteins |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1165750B1 Diagnosis of whipple disease |
| 08/09/2006 | EP1069135B1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 08/09/2006 | EP1051619B1 Method for identifying t-cell stimulating protein fragments |
| 08/09/2006 | EP1021721B1 Assays for tsh receptor autoantibodies |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | EP0939763B1 Directed switch-mediated dna recombination |
| 08/09/2006 | EP0935656B1 Hedgehog interacting proteins and uses related thereto |
| 08/09/2006 | EP0920305B1 Identification of genes altered in multiple myeloma |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0759988B1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 08/09/2006 | EP0640102B1 Activation-state-specific phosphoprotein immunodetection |
| 08/09/2006 | CN1816632A Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 08/09/2006 | CN1816631A Variants of beta-glucosidases |
| 08/09/2006 | CN1816621A Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from comamonas testosteroni 5-MAGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and |
| 08/09/2006 | CN1816562A Protein achieving improved blocking efficiency |
| 08/09/2006 | CN1814782A Method for extracting small molecule collagen protein from fish scale utilizing enzyme engineering technique |
| 08/09/2006 | CN1814781A Method for extracting bitter-free collagen peptide from fish scale utilizing endopeptidase and telopeptidase |
| 08/09/2006 | CN1814780A Method for promoting microbial enzyme process to synthesizing glutathione |
| 08/09/2006 | CN1814779A Method for producing recombinant human granulocyte colony stimulating factor |
| 08/09/2006 | CN1814778A Method for preparing medical collagen protein powder |
| 08/09/2006 | CN1814777A Method for producing compound bioactive peptide utilizing casein enzyme process |
| 08/09/2006 | CN1814776A Egg yolk hypertension-reducing peptide and its preparing method |
| 08/09/2006 | CN1814775A Method for preparing antiviral active oligomeric peptide |
| 08/09/2006 | CN1814772A Animal shell substance treating method and device |
| 08/09/2006 | CN1814755A High-temperature neutral protease and preparing method |
| 08/09/2006 | CN1268762C Corn peptide and its preparation and use |
| 08/09/2006 | CN1268761C Method of preparing human carried lipoprotein gene recombination protein |
| 08/09/2006 | CN1268760C Method for producing fermented nucleotide typed antibiotics by using membrane |
| 08/09/2006 | CN1268751C Purification method of recombinant yeast strain and rhGM-CSF to express human granulocyte-macrophage colony stimulating factor |
| 08/09/2006 | CN1268748C Viral vaccine |